Crossmark

The study of miR-130a expression and its mechanism of action in peripheral blood endothelial progenitor cells (EPCs) in type 2 diabetes mellitus (T2DM)

Crossref DOI link: https://doi.org/10.1038/s41598-025-88507-1

Published Online: 2025-04-01

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Cai, Yawei

Zhu, Yao

Xu, Ning

Chen, Tongen
Funding

Funding for this research was provided by:

Natural Science Foundation of Ningbo (2016A610138)

Technology Plan Project of Zhejiang Medicine and Health Science (2022KY1120)

Key Discipline of Ningbo No.2 Hospital (2023-Y10)
License Information

Text and Data Mining valid from 2025-04-01

Version of Record valid from 2025-04-01
More Information

Article History

Received: 30 July 2024

Accepted: 28 January 2025

First Online: 1 April 2025

Declarations

:

: The ethics committee of Ningbo No.2 Hospital has approved the protocols of this study. All methods were carried out in accordance with the latest version of Declaration of Helsinki. Informed consent was obtained from all subjects before the initiation of this study.

: The authors declare no competing interests.

Document is current

Any future updates will be listed below